TOMM40 regulates hepatocellular and plasma lipid metabolism via an LXR-dependent pathway
Neil Victor YangiD, Justin Y. ChaoiD, Kelly A Garton, Tommy TraniD, Sarah M. KingiD, Joseph Orr, Jacob H Oei, Alexandra P. Crawford, Misun KangiD, Reena Zalpuri, Danielle M. JorgensiD, Pranav KonchadiiD, John S. ChorbaiD, Elizabeth TheuschiD, Ronald M. KraussiD
Abstract
The gene encoding TOMM40 (Transporter of Outer Mitochondrial Membrane 40) is adjacent to that encoding APOE, which has a central role in lipid and lipoprotein metabolism. Human genetic variants near APOE and TOMM40 are strongly associated with plasma lipid levels, but a specific role for TOMM40 in lipid metabolism has not been established. Investigating this, we show that suppression of TOMM40 in human hepatoma cells upregulates expression of APOE and LDLR in part via activation of LXRB (NR1H2) by oxysterols, with consequent increased uptake of VLDL and LDL. This is in part due to disruption of mitochondria-endoplasmic reticulum contact sites, with resulting accrual of reactive oxygen species and non-enzymatically derived oxysterols. With TOMM40 knockdown, cellular triglyceride and lipid droplet content are increased, effects attributable in part to receptor-mediated VLDL uptake, since lipid staining is significantly reduced by concomitant suppression of either LDLR or APOE. In contrast, cellular cholesterol content is reduced due to LXRB-mediated upregulation of the ABCA1 transporter as well as increased production and secretion of oxysterol-derived cholic acid. Consistent with the findings in hepatoma cells, in vivo knockdown of TOMM40 in mice results in significant reductions of plasma triglyceride and cholesterol concentrations, reduced hepatic cholesterol and increased triglyceride content, and accumulation of lipid droplets leading to development of steatosis. These findings demonstrate a role for TOMM40 in regulating hepatic lipid and plasma lipoprotein levels and identify mechanisms linking mitochondrial function with lipid metabolism. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=132 SRC="FIGDIR/small/600910v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@17b0c8forg.highwire.dtl.DTLVardef@17599aaorg.highwire.dtl.DTLVardef@1bb6ab2org.highwire.dtl.DTLVardef@15a035f_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 12
- FWCI
- 1.94
- Field percentile
- top 15%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TOMM40 Knockdown in Macrophages Inhibits Oxidized LDL-induced NLRP3 Activation and Promotes LXR-β Mediated Cholesterol Transporter Gene Expression
Sai S. Chelluri, Neil Victor Yang, … Ronald M. Krauss·bioRxiv·Jul 1, 2025
- Liver-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice
A. K. Singh, B. Chaube, … C. Fernandez-Hernando·bioRxiv·Jun 2, 2020
- TOMM40 suppression promotes neuronal cholesterol imbalance and molecular and behavioral phenotypes of Alzheimer's disease
Neil Victor Yang, Shaowei Wang, … Ronald M. Krauss·Alzheimer s & DementiaPeer-reviewed·Apr 1, 2026
- TRPV4 modulation affects mitochondrial parameters in adipocytes and its inhibition upregulates lipid accumulation
Shamit Kumar, Tusar Kanta Acharya, … Chandan Goswami·Life SciencesPeer-reviewed·Oct 14, 2024
- The COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion
Grigorios Panteloglou, Jérôme Robert, … Arnold von Eckardstein·AtherosclerosisPeer-reviewed·Aug 25, 2026
- TMEM135 is an LXR-Inducible Regulator of Peroxisomal Metabolism
B. J. Renquist, T. W. Madanayake, … R. L. Bogan·bioRxiv·Jun 3, 2019